|
gptkbp:instanceOf
|
gptkb:virus
|
|
gptkbp:biosafetyLevel
|
4
bioterrorism potential
|
|
gptkbp:cause
|
gptkb:Ebola_virus_disease
|
|
gptkbp:discoveredBy
|
gptkb:Peter_Piot
|
|
gptkbp:discoveredIn
|
1976
|
|
gptkbp:enveloped
|
true
|
|
gptkbp:family
|
gptkb:Filoviridae
|
|
gptkbp:firstPerformed
|
gptkb:Yambuku,_Democratic_Republic_of_the_Congo
|
|
gptkbp:genomeType
|
single-stranded RNA
|
|
gptkbp:genus
|
gptkb:Ebolavirus
|
|
gptkbp:hostedBy
|
humans
fruit bats
non-human primates
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Ebola virus
|
|
gptkbp:ICTVdB
|
00.022.0.02.001
|
|
gptkbp:incubationPeriod
|
2-21 days
|
|
gptkbp:mode
|
mucous membranes
broken skin
|
|
gptkbp:mortalityRate
|
25-90%
|
|
gptkbp:namedAfter
|
gptkb:Ebola_River
|
|
gptkbp:naturalHost
|
fruit bats
|
|
gptkbp:notableOutbreaks
|
gptkb:Democratic_Republic_of_the_Congo_2018-2020
gptkb:West_Africa_2014-2016
|
|
gptkbp:order
|
gptkb:Mononegavirales
|
|
gptkbp:prevention
|
avoid contact with infected individuals
safe burial practices
use of personal protective equipment
|
|
gptkbp:product
|
gptkb:RNA-dependent_RNA_polymerase_(L_protein)
gptkb:VP24
gptkb:VP30
gptkb:VP35
gptkb:VP40
gptkb:nucleoprotein_(NP)
glycoprotein (GP)
|
|
gptkbp:relatedTo
|
gptkb:Bundibugyo_virus
gptkb:Reston_virus
gptkb:Sudan_virus
gptkb:Taï_Forest_virus
|
|
gptkbp:shape
|
filamentous
|
|
gptkbp:structure
|
helical nucleocapsid
|
|
gptkbp:symptom
|
fever
vomiting
diarrhea
bleeding
muscle pain
hemorrhagic fever
|
|
gptkbp:taxonRank
|
gptkb:species
186536
|
|
gptkbp:transmission
|
direct contact
bodily fluids
|
|
gptkbp:treatment
|
supportive care
antiviral drugs (experimental)
|
|
gptkbp:vaccineAvailable
|
true
|
|
gptkbp:vaccineType
|
gptkb:rVSV-ZEBOV
|
|
gptkbp:bfsParent
|
gptkb:lion
gptkb:vaccine
|
|
gptkbp:bfsLayer
|
4
|